Heckmann, Markus B.
Finke, Daniel
Sauerbrey, Leander
Frey, Norbert
Lehmann, Lorenz H.
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 18 October 2023
Accepted: 4 July 2024
First Online: 20 July 2024
Declarations
:
: Not applicable.
: Not applicable.
: D.F., L.S., N.F. declare no conflict of interest. LHL has served on the advisory board for Daiichi Sankyio, Senaca, Astra Zeneca and Servier, as an external expert for Astra Zeneca and received speakers’ honoraria from Novartis and MSD. M.H. received speakers’ honaria from Bristol Myers Squibb and Daiichi Sankyo. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.